Results 241 to 250 of about 124,080 (339)

Characteristics of gross motor function among children with spastic cerebral palsy aged between 2–4 years

, 2020

openalex   +1 more source

Modeling cerebral palsy in animals

Developmental Medicine &Child Neurology, EarlyView.
Abstract Advancements in the treatment of cerebral palsy depend on animal research. Yet, most animal models have not been fully evaluated for spasticity and dystonia using clinically relevant measures of altered tone or movement patterns, which form the basis for diagnosing people with the condition.
Katharina A. Quinlan, Emily J. Reedich, Elvia Mena Avila, Brendan C. Moline, Landon T. Genry, Megan R. Detloff, Benjamin R. Katholi, Deborah Gaebler‐Spira, Bhooma R. Aravamuthan   +8 more
wiley   +1 more source

A novel <i>KIDINS220</i> mutation associated with hereditary spastic paraplegia accompanied by severe peripheral neuropathy. [PDF]

Front Neurosci
Chu X, Xu J, Zheng Y, Liu X, Yuan Y, Wu R.   +5 more
europepmc   +1 more source

Restoring adapter protein complex 4 function with small molecules: an in silico approach to spastic paraplegia 50

San Francisco, Lorenzo Lamacchia, Alberto Turco, Giuseppe Ermondi, Giulia Caron, Matteo Rossi Sebastiano   +5 more
openalex   +1 more source

Ultra-selective Conus Dorsal Rhizotomy for Spasticity; Technical Note and Step-by-Step Operative Technique [PDF]

Hussein Hamdi, Ali Nada, Nahla Hekal, Samia Moharram, Ahmed Morsy, Ahmed Balaha, Ayman M. Al-Malt, Ali M. Omran, Heba A. Elmokadem, Rania Saed   +9 more
openalex   +1 more source

Epidemiology of progressive intellectual and neurological deterioration in UK children

Developmental Medicine &Child Neurology, EarlyView.
This study of PIND in UK children was carried out via the British Paediatric Surveillance Unit from 1997 to 2024. It identified six cases of vCJD. 2367 children had other diagnoses explain their deterioration. There were 259 other diseases in the diagnosed group.
Christopher M. Verity, Polly J. Maunder, Anne Marie Winstone, Suvankar Pal   +3 more
wiley   +1 more source

The Neuro-Ophthalmologic Manifestations of <i>SPG7</i>-Associated Disease. [PDF]

J Pers Med
Jauregui R, Diaz Curbelo C, Galetta SL, Grossman SN.   +3 more
europepmc   +1 more source

Three‐year outcomes of repeated botulinum neurotoxin A injections to the lower extremities in young children with spastic cerebral palsy in GMFCS levels I to III

Developmental Medicine &Child Neurology, EarlyView.
In this study, we followed a group of children 2 to 6 years old with spastic cerebral palsy functioning in GMFCS levels I–III, over 3 years. Sixty‐five received BoNT‐A and 59 did not. Repeated BoNT‐A injections over 3 years were not associated with improvements in gross motor function or passive ankle dorsiflexion. Daily step counts, favouring the BoNT‐
Darcy Fehlings, Emma Bohn, Lauren Switzer, Charles H. Goldsmith, Unni Narayanan, Peter L. Rosenbaum, F. Virginia Wright, Gary Foster, CP‐BoNT‐A Study Group, Timothy Carey, Mark Mason, Ronit Mesterman   +11 more
wiley   +1 more source

Spastic Ataxia Composite (SPAXCOM): A Scale to Evaluate the Progression of Subjects with Spasticity and Ataxia. [PDF]

Mov Disord
Di Folco C, Dubec-Fleury C, Traschütz A, Kessler C, Reich S, Gagnon C, Lessard I, Rodrigue X, Cocozza S, Satolli S, Santorelli FM, Durr A, Heinzmann A, van de Warrenburg BP, Willemse IHJ, Başak AN, Vural A, Brais B, Klebe S, Horvath R, PROSPAX Consortium, Schüle R, Synofzik M, Tezenas du Montcel S.   +23 more
europepmc   +1 more source

Longitudinal assessment of the upper limb in adults with cerebral palsy

Developmental Medicine &Child Neurology, EarlyView.
Prue Morgan
wiley   +1 more source